Description

Maxgystin (betahistine dihydrochloride) tablets 24 mg. №30

Ingredients

Active ingredient: Betahistine dihydrochloride 24 mg.

Dosage

Recommended dosage: 1 tablet three times daily with meals.

Indications

Maxgystin tablets are indicated for the treatment of Meniere’s disease and vertigo associated with disorders of the vestibular system.

Contraindications

Do not use Maxgystin tablets if you are allergic to betahistine or any other ingredients in the product. Consult your healthcare provider before use if you are pregnant or breastfeeding.

Directions

Take Maxgystin tablets exactly as prescribed by your healthcare provider. Swallow the tablets whole with a glass of water during meals to minimize gastrointestinal side effects.

Scientific Evidence

Betahistine dihydrochloride has been extensively studied for its efficacy in treating symptoms of Meniere’s disease and vertigo. Research has shown that betahistine acts as a histamine H3 receptor antagonist, improving inner ear blood flow and reducing the frequency and intensity of vertigo attacks.

Additional Information

Maxgystin tablets may cause mild gastrointestinal side effects such as nausea or stomach upset. If these symptoms persist or worsen, contact your healthcare provider. It is important to follow a balanced diet and stay hydrated while taking this medication.

Pharmacologically, betahistine dihydrochloride works by improving blood flow in the inner ear, which helps to reduce the pressure and fluid buildup responsible for vertigo and balance issues. This mechanism of action makes it an effective treatment for Meniere’s disease.

Clinical trials have demonstrated the effectiveness of betahistine dihydrochloride in reducing the frequency and severity of vertigo attacks in patients with Meniere’s disease. A study published in the International Journal of Audiology showed a significant improvement in vertigo symptoms and quality of life in patients treated with betahistine compared to a placebo group.